1. Home
  2. CNTA vs CASH Comparison

CNTA vs CASH Comparison

Compare CNTA & CASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • CASH
  • Stock Information
  • Founded
  • CNTA 2020
  • CASH 1954
  • Country
  • CNTA United Kingdom
  • CASH United States
  • Employees
  • CNTA N/A
  • CASH N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • CASH Major Banks
  • Sector
  • CNTA Health Care
  • CASH Finance
  • Exchange
  • CNTA Nasdaq
  • CASH Nasdaq
  • Market Cap
  • CNTA 1.6B
  • CASH 1.8B
  • IPO Year
  • CNTA 2021
  • CASH N/A
  • Fundamental
  • Price
  • CNTA $14.29
  • CASH $83.04
  • Analyst Decision
  • CNTA Strong Buy
  • CASH Buy
  • Analyst Count
  • CNTA 10
  • CASH 2
  • Target Price
  • CNTA $28.78
  • CASH $91.00
  • AVG Volume (30 Days)
  • CNTA 980.2K
  • CASH 207.3K
  • Earning Date
  • CNTA 08-12-2025
  • CASH 07-23-2025
  • Dividend Yield
  • CNTA N/A
  • CASH 0.24%
  • EPS Growth
  • CNTA N/A
  • CASH 10.71
  • EPS
  • CNTA N/A
  • CASH 7.36
  • Revenue
  • CNTA $15,000,000.00
  • CASH $731,383,000.00
  • Revenue This Year
  • CNTA N/A
  • CASH $14.15
  • Revenue Next Year
  • CNTA N/A
  • CASH $5.99
  • P/E Ratio
  • CNTA N/A
  • CASH $11.28
  • Revenue Growth
  • CNTA 118.88
  • CASH 6.51
  • 52 Week Low
  • CNTA $9.00
  • CASH $58.74
  • 52 Week High
  • CNTA $19.09
  • CASH $86.00
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 61.38
  • CASH 64.55
  • Support Level
  • CNTA $13.22
  • CASH $78.76
  • Resistance Level
  • CNTA $14.74
  • CASH $84.83
  • Average True Range (ATR)
  • CNTA 0.73
  • CASH 1.83
  • MACD
  • CNTA 0.14
  • CASH 0.60
  • Stochastic Oscillator
  • CNTA 85.11
  • CASH 83.39

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

Share on Social Networks: